Potassium channels Kv1.3 and KCa3.1 cooperatively and compensatorily regulate antigen-specific memory T cell functions
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Voltage-gated Kv1.3 and Ca 2+-dependent KCa3.1 are the most prevalent K+channels expressed by human and rat T cells. Despite the preferential upregulation of Kv1.3 over KCa3.1 on autoantigen-experienced effector memory T cells, whether Kv1.3 is required for their induction and function is unclear. Here we show, using Kv1.3-deficient rats, that Kv1.3 is involved in the development of chronically activated antigen-specific T cells. Several immune responses are normal in Kv1.3 knockout (KO) rats, suggesting that KCa3.1 can compensate for the absence of Kv1.3 under these specific settings. However, experiments with Kv1.3 KO rats and Kv1.3 siRNA knockdown or channel-specific inhibition of human T cells show that maximal T-cell responses against autoantigen or repeated tetanus toxoid stimulations require both Kv1.3 and KCa3.1. Finally, our data also suggest that T-cell dependency on Kv1.3 or KCa3.1 might be irreversibly modulated by antigen exposure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The homo-tetrameric form of Kv1.3 channels that is susceptible to blockade by ShK analogs (such as ShK-223) is uniquely expressed in the brain by activated microglia while Kv1.3 hetero-tetramers that are resistant to ShK analogs are expressed by some cortical neurons [60, 61].”
From Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease (2018) · cites this paper as [60]
Experimental — accuracy not yet measuredIn the citing paper
“The homo-tetrameric form of Kv1.3 channels that is susceptible to blockade by ShK analogs (such as ShK-223) is uniquely expressed in the brain by activated microglia while Kv1.3 hetero-tetramers that are resistant to ShK analogs are expressed by some cortical neurons [60, 61].”
From Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease (2018) · cites this paper as [60]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of the Voltage Gated K+ Channel Kv1.3 by Recombinant Human Klotho Protein
Almilaji, A., Honisch, S., Liu, G., Elvira, B., Ajay, S. S., Hosseinzadeh, Z., Ahmed, M., Munoz, C., Sopjani, M., & Lang, F. (2014) · Kidney and Blood Pressure Research · doi:10.1159/000368472 · Cited by 5,592
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856
Molecular Mechanisms RegulatinG Th1 Immune Responses
Szabo, S. J., Sullivan, B. M., Peng, S. L., & Glimcher, L. H. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.140942 · Cited by 1,019
Ion Channels in Innate and Adaptive Immunity
Feske, S., Wulff, H., & Skolnik, E. Y. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112212 · Cited by 768
Wulff, H., Miller, M. J., Hänsel, W., Grissmer, S., Cahalan, M. D., & Chandy, K. G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.8151 · Cited by 604
The functional network of ion channels in T lymphocytes
Cahalan, M. D., & Chandy, K. G. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00816.x · Cited by 599
Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases
Beeton, C., Wulff, H., Standifer, N. E., Azam, P., Mullen, K. M., Pennington, M. W., Kolski-Andreaco, A., Wei, E., Grino, A., Counts, D. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605136103 · Cited by 538
Ion channels and transporters in lymphocyte function and immunity
Feske, S., Skolnik, E. Y., & Prakriya, M. (2012) · Nature Reviews Immunology · doi:10.1038/nri3233 · Cited by 441
K+ channels as targets for specific immunomodulation
George Chandy, K., Wulff, H., Beeton, C., Pennington, M., Gutman, G. A., & Cahalan, M. D. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.03.010 · Cited by 427
The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS
Wulff, H., Calabresi, P. A., Allie, R., Yun, S., Pennington, M., Beeton, C., & Chandy, K. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16921 · Cited by 422
Up-regulation of the IKCa1 Potassium Channel during T-cell Activation
Ghanshani, S., Wulff, H., Miller, M. J., Rohm, H., Neben, A., Gutman, G. A., Cahalan, M. D., & Chandy, K. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003941200 · Cited by 406
Diversity in T Cell Memory: An Embarrassment of Riches
Jameson, S. C., & Masopust, D. (2009) · Immunity · doi:10.1016/j.immuni.2009.11.007 · Cited by 382
Beeton, C., Wulff, H., Barbaria, J., Clot-Faybesse, O., Pennington, M., Bernard, D., Cahalan, M. D., Chandy, K. G., & Béraud, E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241497298 · Cited by 318
Wirth, T. C., Xue, H.-H., Rai, D., Sabel, J. T., Bair, T., Harty, J. T., & Badovinac, V. P. (2010) · Immunity · doi:10.1016/j.immuni.2010.06.014 · Cited by 261
The ion channel TRPV1 regulates the activation and proinflammatory properties of CD4+ T cells
Bertin, S., Aoki-Nonaka, Y., de Jong, P. R., Nohara, L. L., Xu, H., Stanwood, S. R., Srikanth, S., Lee, J., To, K., Abramson, L., et al. (2014) · Nature Immunology · doi:10.1038/ni.3009 · Cited by 260
ShK-Dap22, a Potent Kv1.3-specific Immunosuppressive Polypeptide
Kalman, K., Pennington, M. W., Lanigan, M. D., Nguyen, A., Rauer, H., Mahnir, V., Paschetto, K., Kem, W. R., Grissmer, S., Gutman, G. A., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32697 · Cited by 256
Beeton, C., Pennington, M. W., Wulff, H., Singh, S., Nugent, D., Crossley, G., Khaytin, I., Calabresi, P. A., Chen, C.-Y., Gutman, G. A., et al. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008193 · Cited by 249
Schmitz, A., Sankaranarayanan, A., Azam, P., Schmidt-Lassen, K., Homerick, D., Hänsel, W., & Wulff, H. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.015669 · Cited by 226
Memory CD8 T-cell compartment grows in size with immunological experience
Vezys, V., Yates, A., Casey, K. A., Lanier, G., Ahmed, R., Antia, R., & Masopust, D. (2009) · Nature · doi:10.1038/nature07486 · Cited by 218
Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases
Chi, V., Pennington, M. W., Norton, R. S., Tarcha, E. J., Londono, L. M., Sims-Fahey, B., Upadhyay, S. K., Lakey, J. T., Iadonato, S., Wulff, H., et al. (2012) · Toxicon · doi:10.1016/j.toxicon.2011.07.016 · Cited by 213
Matheu, M. P., Beeton, C., Garcia, A., Chi, V., Rangaraju, S., Safrina, O., Monaghan, K., Uemura, M. I., Li, D., Pal, S., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.07.015 · Cited by 196
Beeton, C., Barbaria, J., Giraud, P., Devaux, J., Benoliel, A.-M., Gola, M., Sabatier, J. M., Bernard, D., Crest, M., & Béraud, E. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.936 · Cited by 191
Rus, H., Pardo, C. A., Hu, L., Darrah, E., Cudrici, C., Niculescu, T., Niculescu, F., Mullen, K. M., Allie, R., Guo, L., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501770102 · Cited by 184
Targeted depletion of lymphotoxin-α–expressing TH1 and TH17 cells inhibits autoimmune disease
Chiang, E. Y., Kolumam, G. A., Yu, X., Francesco, M., Ivelja, S., Peng, I., Gribling, P., Shu, J., Lee, W. P., Refino, C. J., et al. (2009) · Nature Medicine · doi:10.1038/nm.1984 · Cited by 181
Self-citationThe voltage-gated potassium channel Kv1.3 regulates energy homeostasis and body weight
Xu, J. (2003) · Human Molecular Genetics · doi:10.1093/hmg/12.5.551 · Cited by 149
Engineering a Stable and Selective Peptide Blocker of the Kv1.3 Channel in T Lymphocytes
Pennington, M. W., Beeton, C., Galea, C. A., Smith, B. J., Chi, V., Monaghan, K. P., Garcia, A., Rangaraju, S., Giuffrida, A., Plank, D. W., et al. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.052704 · Cited by 138
Tarcha, E. J., Chi, V., Muñoz-Elías, E. J., Bailey, D., Londono, L. M., Upadhyay, S. K., Norton, K., Banks, A., Tjong, I., Nguyen, H., et al. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.191890 · Cited by 117
Meuth, S. G., Bittner, S., Meuth, P., Simon, O. J., Budde, T., & Wiendl, H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800637200 · Cited by 112
Potassium Channels, Memory T Cells, and Multiple Sclerosis
Beeton, C., & Chandy, K. G. (2005) · The Neuroscientist · doi:10.1177/1073858405278016 · Cited by 111
PENNINGTON, M. W., BYRNES, M. E., ZAYDENBERG, I., KHAYTIN, I., DE CHASTONAY, J., KRAFTE, D. S., HILL, R., MAHNIR, V. M., VOLBERG, W. A., GORCZYCA, W., et al. (1995) · International Journal of Peptide and Protein Research · doi:10.1111/j.1399-3011.1995.tb01068.x · Cited by 104
Kv1.3 potassium channels as a therapeutic target in multiple sclerosis
Rangaraju, S., Chi, V., Pennington, M. W., & Chandy, K. G. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903018957 · Cited by 99
Azam, P., Sankaranarayanan, A., Homerick, D., Griffey, S. M., & Wulff, H. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700717 · Cited by 94
Chhabra, S., Chang, S. C., Nguyen, H. M., Huq, R., Tanner, M. R., Londono, L. M., Estrada, R., Dhawan, V., Chauhan, S., Upadhyay, S. K., et al. (2014) · The FASEB Journal · doi:10.1096/fj.14-251967 · Cited by 91
Compensatory Anion Currents in Kv1.3 Channel-deficient Thymocytes
Koni, P. A., Khanna, R., Chang, M. C., Tang, M. D., Kaczmarek, L. K., Schlichter, L. C., & Flavell, R. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304879200 · Cited by 87
Chen, G., Panicker, S., Lau, K., Apparsundaram, S., Patel, V. A., Chen, S.-L., Soto, R., Jung, J., Ravindran, P., Okuhara, D. Y., et al. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2012.12.011 · Cited by 74
Blocking KV1.3 Channels Inhibits Th2 Lymphocyte Function and Treats a Rat Model of Asthma
Koshy, S., Huq, R., Tanner, M. R., Atik, M. A., Porter, P. C., Khan, F. S., Pennington, M. W., Hanania, N. A., Corry, D. B., & Beeton, C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.517037 · Cited by 66
Targeting effector memory T-cells with Kv1.3 blockers.
Wulff, H., & Pennington, M. W. (2007) · PubMed · Cited by 60
Panyi, G. (2005) · European Biophysics Journal · doi:10.1007/s00249-005-0499-3 · Cited by 54
Li, Z., Liu, W., Han, S. H., Peng, B., Yin, J., Wu, Y., He, X., & Li, W. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.379594 · Cited by 51
Szigligeti, P., Neumeier, L., Duke, E., Chougnet, C. A., Takimoto, K., Lee, S. M., Filipovich, A. H., & Conforti, L. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.109967 · Cited by 49
Yang, J., James, E. A., Sanda, S., Greenbaum, C., & Kwok, W. W. (2013) · Immunology · doi:10.1111/imm.12034 · Cited by 44
Edwards, W., Fung‐Leung, W., Huang, C., Chi, E., Wu, N., Liu, Y., Maher, M. P., Bonesteel, R., Connor, J., Fellows, R., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.568642 · Cited by 33
Pelegrı́, C., Morante, M. P., Castellote, C., Franch, À., & Castell, M. (1996) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1996.d01-624.x · Cited by 27
The Longevity of Memory CD8 T Cell Responses after Repetitive Antigen Stimulations
Rai, D., Martin, M. D., & Badovinac, V. P. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301063 · Cited by 26
Wang, J., & Xiang, M. (2013) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1236 · Cited by 25
Hoffmann, J., Herklotz, C., Zeidler, H. K., Bayer, B., ROSENTHAL, H., & Westermann, J. (1997) · Annals of the Rheumatic Diseases · doi:10.1136/ard.56.12.716 · Cited by 25
Influence of time and number of antigen encounters on memory CD8 T cell development
Martin, M. D., & Badovinac, V. P. (2014) · Immunologic Research · doi:10.1007/s12026-014-8522-3 · Cited by 22
Ueyama, A., Imura, K., Kasai-Yamamoto, E., Tai, N., Nagira, M., Shichijo, M., & Yasui, K. (2013) · Clinical and Experimental Dermatology · doi:10.1111/ced.12097 · Cited by 11
Human T cells in silico: Modelling their electrophysiological behaviour in health and disease
Ehling, P., Meuth, P., Eichinger, P., Herrmann, A. M., Bittner, S., Pawlowski, M., Pankratz, S., Herty, M., Budde, T., & Meuth, S. G. (2016) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2016.06.001 · Cited by 10
Ohya, S., Nakamura, E., Sayuri, H., Kito, H., Matsui, M., Yamamura, H., & Imaizumi, Y. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12215 · Cited by 9
Cited by
Rangaraju, S., Dammer, E. B., Raza, S. A., Rathakrishnan, P., Xiao, H., Gao, T., Duong, D. M., Pennington, M. W., Lah, J. J., Seyfried, N. T., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0254-8 · Cited by 430
“3 hetero-tetramers that are resistant to ShK analogs are expressed by some cortical neurons [60, 61].”
BackgroundAntibodies and venom peptides: new modalities for ion channels
Wulff, H., Christophersen, P., Colussi, P., Chandy, K. G., & Yarov-Yarovoy, V. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0013-8 · Cited by 182
Tarcha, E. J., Olsen, C. M., Probst, P., Peckham, D., Muñoz-Elías, E. J., Kruger, J. G., & Iadonato, S. P. (2017) · PLOS ONE · doi:10.1371/journal.pone.0180762 · Cited by 167
NLRP3-dependent pyroptosis is required for HIV-1 gp120-induced neuropathology
He, X., Yang, W., Zeng, Z., Wei, Y., Gao, J., Zhang, B., Li, L., Liu, L., Wan, Y., Zeng, Q., et al. (2019) · Cellular and Molecular Immunology · doi:10.1038/s41423-019-0260-y · Cited by 150
Peptide blockers of Kv1.3 channels in T cells as therapeutics for autoimmune disease
Chandy, K. G., & Norton, R. S. (2017) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2017.02.015 · Cited by 139
Metadata
- Authors
- Chiang, E. Y., Li, T., Jeet, S., Peng, I., Zhang, J., Lee, W. P., DeVoss, J., Caplazi, P., Chen, J., Warming, S., Hackos, D. H., Mukund, S., Koth, C. M., & Grogan, J. L.
- Affiliations
- Genentech (US)
- Corresponding author
- Grogan, Jane L.
- ORCID
- Venue
- Nature Communications
- Published
- 2017-03-01
- Volume
- 8
- Issue
- 1
- Pages
- 14644-14644
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5337993
- OpenAlex
- W2594633730
- Cited by
- 108
- References
- 50
- Citations by year
- 2026: 10 · 2025: 19 · 2024: 6 · 2023: 11 · 2022: 8 · 2021: 12 · 2020: 14 · 2019: 14 · 2018: 6 · 2017: 7
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Keywords
- Kv1.3 potassium channel, memory T cells, autoantigen-specific T cells, tetanus toxoid, antigen exposure, T cell signaling
- MeSH terms
- Animals, Epitopes, Humans, Immunity, Immunologic Memory, Lymphocyte Activation, Phenotype, T-Lymphocytes, Potassium Channel Blockers, RNA, Small Interfering, Rats, Intermediate-Conductance Calcium-Activated Potassium Channels, Kv1.3 Potassium Channel, Gene Knockdown Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.